1. Home
  2. FGEN vs INDO Comparison

FGEN vs INDO Comparison

Compare FGEN & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • INDO
  • Stock Information
  • Founded
  • FGEN 1993
  • INDO 2018
  • Country
  • FGEN United States
  • INDO Indonesia
  • Employees
  • FGEN N/A
  • INDO N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • INDO Oil & Gas Production
  • Sector
  • FGEN Health Care
  • INDO Energy
  • Exchange
  • FGEN Nasdaq
  • INDO Nasdaq
  • Market Cap
  • FGEN 33.5M
  • INDO 35.1M
  • IPO Year
  • FGEN 2014
  • INDO 2019
  • Fundamental
  • Price
  • FGEN $5.30
  • INDO $3.06
  • Analyst Decision
  • FGEN Strong Buy
  • INDO
  • Analyst Count
  • FGEN 1
  • INDO 0
  • Target Price
  • FGEN $250.00
  • INDO N/A
  • AVG Volume (30 Days)
  • FGEN 53.3K
  • INDO 8.3M
  • Earning Date
  • FGEN 08-05-2025
  • INDO 07-01-2025
  • Dividend Yield
  • FGEN N/A
  • INDO N/A
  • EPS Growth
  • FGEN N/A
  • INDO N/A
  • EPS
  • FGEN N/A
  • INDO N/A
  • Revenue
  • FGEN $6,996,000.00
  • INDO $2,667,508.00
  • Revenue This Year
  • FGEN N/A
  • INDO N/A
  • Revenue Next Year
  • FGEN N/A
  • INDO N/A
  • P/E Ratio
  • FGEN N/A
  • INDO N/A
  • Revenue Growth
  • FGEN N/A
  • INDO N/A
  • 52 Week Low
  • FGEN $4.50
  • INDO $2.06
  • 52 Week High
  • FGEN $38.25
  • INDO $7.95
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 31.98
  • INDO 46.48
  • Support Level
  • FGEN $5.22
  • INDO $4.54
  • Resistance Level
  • FGEN $5.85
  • INDO $7.95
  • Average True Range (ATR)
  • FGEN 0.59
  • INDO 0.93
  • MACD
  • FGEN -0.17
  • INDO -0.09
  • Stochastic Oscillator
  • FGEN 4.72
  • INDO 11.09

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

Share on Social Networks: